市場調查報告書

族群基因學:國家策略與實行

Population Genomics: National Strategy and Implementation

出版商 BIS Research Inc. 商品編碼 906050
出版日期 內容資訊 英文 40 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
族群基因學:國家策略與實行 Population Genomics: National Strategy and Implementation
出版日期: 2019年07月31日內容資訊: 英文 40 Pages
簡介

本報告提供全球主要國家中實施的全基因譯解 (WGS)的主要舉措的相關調查,各地區主要的趨勢,產業的聯盟,主要策略和未來展望等相關分析。

摘要整理

第1章 族群基因學:國家策略與實行

  • 公共衛生和基因學
  • 族群基因學的演進

第2章 族群基因學計劃實行的地區策略

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 愛沙尼亞
    • 德國
    • 法國
    • 荷蘭
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
  • 中東
    • 沙烏地阿拉伯
    • 卡達
    • 土耳其
    • 杜拜

第3章 針對族群基因學的實施在世界導入的創新策略

  • 共同實施
  • 跨境基因數據庫的實施
  • 實行計劃的焦點
  • 民間部門的介入

第4章 醫療保健對產業的影響

第5章 族群基因學:現狀、展望

  • 跟官方的聯合擴大
  • 定序成本低
  • 針對組成架構、醫療費償付政策的開發的政府措施
  • 民間部門的介入
  • 族群的參與度、資料管理的擴大

第6章 族群基因學的產業展望

目錄
Product Code: BH140A

Population Genomics-National Initiatives and Implementation, Reports BIS Research

Population genomics initiatives launched in several nations have significantly transformed the entire healthcare industry. With the advancements in technology and the allocation of government funding for the implementation of these programs has profoundly reshaped the current clinical practice. The decreasing cost of genome sequencing and the development of advanced of bioinformatics tools for the analysis of genomic data has facilitated the development of personalized treatment modules. The increased focus of the government for the implementation of population-based sequencing programs has fostered the rapid growth of precision medicine in the medical industry.

The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression. Population genomics initiatives such as All of Us and UK 100K Genomes Project have been initiated to enhance the adoption of genomic medicine and consequentially increasing the awareness among patients and healthcare providers.

This strategic report provides a multidimensional view of the strategic evolution of the ongoing population genomic initiatives. The purpose of the study is to gain a holistic view of the active population-based sequencing projects implemented in several countries. The report contains the analysis of various such as recent trends, technological advancements, reimbursement scenario, and national level initiatives across the globe influencing the adoption of population genomics. The scope of this report is centered upon conducting a detailed study of the strategies, best R&D practices across the globe, and understanding the focus of eminent stakeholders contributing in augmenting the growth of population genomics initiative.

This research report aims at answering various aspects of the population genomics initiatives with the help of the key strategies adopted by different nations for the successful implementation of the program. The report also covers the current status and future perspective of the national population-based sequencing programs that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market.

The research study highlights the key initiatives implemented by several nations across the globe for the whole genome sequencing of its populations. Moreover, the study includes detailed analysis of key trends in multiple geographical regions, industrial partnerships in each region, key strategies and adopted by various nations and future perspectives of the initiatives.

The answers to the following key questions can be derived from this report:

  • How does the emergence of population-based sequencing initiatives is transforming the current clinical practice?
  • Which are the ongoing initiatives that have been implemented by different regions such as North America, Europe, Asia-Pacific and Middle East to promote the acceptance of genomic medicine?
  • What is the role of key stakeholders in aligning the fortune of population genomics?
  • What are the innovative strategies adopted across the world for implementation of population genomics?
  • What is the plausible market penetration strategy for the precision medicine market?
  • What are the current value assessment and the future perspective of population genomics initiatives?
  • What is the scope of industrial participation in the ongoing population genomic initiatives?

Table of Contents

Executive Summary

  • Figure 1: Journey of a Population Genomics Initiative:
  • Figure 2: Active Population Genomics Initiatives:
  • Figure 3: Incorporation of Genomics into Healthcare:

1 Population Genomics: National Strategy and Implementation

  • Figure 1.1: Population Genomics Initiative Workflow.
  • 1.1 Public Health and Genomics
  • Figure 1.2: Objectives of Public Health Genomics
  • Table 1.1: Challenges in Public Health Genomics
  • 1.2 Evolution of Population Genomics
  • Figure 1.3: Evolution of Population Genomics

2 Regional Strategy for Implementation of Population Genomics Projects

  • 2.1 North America
  • 2.1.1 U.S.
  • Table 2.1: Population Genomic Initiatives in U.S.
  • Table 2.2: Funding Allocated to Different Agencies
  • 2.1.2 Canada
  • Table 2.3: Population Genomic Initiatives in Canada
  • Table 2.4: National and International Initiatives in Canada
  • Table 2.5: Ongoing Population Genomics Program
  • 2.1.2.1 Population Genomics Program
  • 2.2 Europe
  • Table 2.6: European Initiatives for Implementation of Population Genomics
  • 2.2.1 The U.K.
  • Table 2.7: Population Genomic Initiatives in U.K.
  • 2.2.1.1 Industrial Partnership Directing the Course of Genomic Medicine
  • Table 2.8: Key Investments Driving Genomic Medicine in the U.K.
  • Table 2.9: Genomic Medicine Centers in the U.K.
  • 2.2.2 Estonia
  • Table 2.10: Population Genomic Initiatives in Estonia
  • 2.2.3 Germany
  • Table 2.11: Population Genomic Initiatives in Germany
  • 2.2.4 France
  • Table 2.12: Population Genomic Initiatives in China
  • Table 2.13: French Genomic Platform
  • 2.2.5 Ireland
  • Table 2.14: Population Genomic Initiatives in Ireland
  • 2.2.6 The Netherlands
  • Table: 2.15 Population Genomic Initiatives in the Netherlands
  • 2.2.7 Denmark
  • Table 2.16: Population Genomic Initiatives in Denmark
  • 2.3 Asia Pacific
  • 2.3.1 Japan
  • Table 2.17: Population Genomic Initiatives in Japan
  • 2.3.2 China
  • Table 2.18: Population Genomic Initiatives in China
  • 2.3.3 Australia
  • Table 2.19: Population Genomic Initiatives in Australia
  • 2.4 Middle East
  • 2.4.1 Saudi Arabia
  • Table 2.20: Population Genomic Initiatives in Saudi Arabia
  • 2.4.2 Qatar
  • Table 2.21: Population Genomic Initiatives in Qatar
  • 2.4.3 Turkey
  • Table 2.22: Population Genomic Initiatives in Turkey
  • 2.4.4 Dubai
  • Table 2.23: Population Genomic Initiatives in Dubai

3 Innovative Strategies Adopted Across the World for Implementation of Population Genomics

  • Figure 3.1: Member of the GENE Consortium
  • 3.1 Collaborative Implementation
  • 3.2 Implementation of Cross-Border Genome Data Bank
  • 3.3 Focused Implementation Program
  • 3.4 Involvement of the Private Sector

4 Impact on Healthcare Industry

  • Figure 4.1: Impact of Population Genomics on Healthcare Industry

5 Population Genomics: Current State and Perspectives

  • Figure 5.1: Current Status of Population Genomics
  • Figure 5.2: Future Perspective of Population Genomics
  • 5.1 Growing Public-Partnerships
  • 5.2 Decrease in Sequencing Cost
  • Figure 5.3: Fall in Genome Sequencing Cost
  • 5.3 Government Initiatives for Development of Framework and Reimbursement Policy
  • 5.4 Involvement of the Private Sector
  • 5.5 Increased Population Engagement and Data Management

6 Industrial Perspective for Population Genomics

  • Figure 6.1: Participation of Industry in Population Genomics
Back to Top